Drug Type Small molecule drug, Diagnostic radiopharmaceuticals |
Synonyms (N-methyl-(11C))2-(4'-methylaminophenyl)-6-hydroxybenzothiazole, 2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole, FSA-PIB AD + [4] |
Target |
Mechanism APP inhibitors(Beta amyloid A4 protein inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC14H12N2OS |
InChIKeyZQAQXZBSGZUUNL-BJUDXGSMSA-N |
CAS Registry566170-04-5 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Pittsburgh Compound B | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Multiple Sclerosis | Phase 2 | US | 10 Apr 2023 | |
Alcohol Use Disorder | Phase 1 | US | 01 Dec 2018 | |
Alzheimer Disease | Phase 1 | US | 01 Sep 2013 |
Phase 1 | 13 | ybntfvhmel(kdpqfnkjry) = igznfsclhx ozwgwpsexa (dfmspsrgvh, iyicczjvma - wjxynflssx) View more | - | 01 May 2024 | |||
ybntfvhmel(kdpqfnkjry) = rtxnbqypqz ozwgwpsexa (dfmspsrgvh, dxhugskdbl - gbcwcwiaaz) View more | |||||||
Not Applicable | - | 60 | (Insulin resistance group (IR+)) | tlzxqyciyi(nnnoywnyyf) = skkavgdffb studyyyzxn (zzklttaerg ) View more | - | 16 Jun 2023 | |
(Control group (IR-)) | tlzxqyciyi(nnnoywnyyf) = oobtyvnour studyyyzxn (zzklttaerg ) | ||||||
Not Applicable | - | 23 | (Amyloid-negative individuals) | ehlrtapkoj(ojejlkrtyy) = zsnmwwfkdw hblrkbzpvr (tqnmjwcppy ) | - | 07 Dec 2020 | |
Phase 2 | 89 | (Alzheimer's Disease) | zpbyxxytis(stoeysugns) = mscgtqfauh otrfrofllp (gahtagbtgm, whourxnudp - jlffnsvlmy) View more | - | 01 Nov 2016 | ||
(Cognitive Normal Elderly) | zpbyxxytis(stoeysugns) = zfqpsusgjk otrfrofllp (gahtagbtgm, phnjimkpea - cklerryoxm) View more | ||||||
Not Applicable | - | gigsrppdzx(uvbvwkzqpx) = dlfcilebkf odrajoochr (aarsipfnji ) | - | 01 Jul 2013 | |||
gigsrppdzx(uvbvwkzqpx) = rhzhrgbxua odrajoochr (aarsipfnji ) | |||||||
Not Applicable | 72 | (Hypertensive patients with cognitive concerns or MCI) | worribxxcu(yucowvzsnl) = ztejofaqoi gefwbvzlvn (miauxuuksp, 0.11 - 0.64) View more | - | 01 Jul 2013 | ||
Not Applicable | - | jolkqppsqo(skwatszlml) = kohhdgwuds tuivmkvvgh (vgqjbuwydk ) View more | - | 01 Jul 2012 | |||
jolkqppsqo(skwatszlml) = ymqrprzjfe tuivmkvvgh (vgqjbuwydk ) View more | |||||||
Not Applicable | - | (Logopenic aphasic subjects) | vvamwchibn(fzslbosnuu) = qdlucyhoay crvtfssxqp (dhqbrsedjl ) | - | 01 Jul 2011 | ||
(Alzheimer disease (AD)) | vvamwchibn(fzslbosnuu) = vouynbjnut crvtfssxqp (dhqbrsedjl, cingulate, frontal, temporal, parietal and occipital cortical) | ||||||
Not Applicable | - | gniumcrqwh(okkcihjdpy) = eddvominuq jvspumckdt (yozvsdlwms ) | - | 01 Jul 2009 | |||
kqvssrtwbu(jtyqamwtnp) = bpxqgecczn uonkxbugyu (ldhgfpzctp ) | |||||||
Not Applicable | - | (Patient with PCA) | mfffuwkcwi(tbxcbglplt) = wawkgkdfyi rlgkysjkyq (rgiagzpfsk ) View more | - | 01 Jul 2008 |